These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36544387)

  • 1. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis.
    Shridhar R; Blinn P; Huston J; Meredith KL
    Cancer; 2023 Mar; 129(6):890-900. PubMed ID: 36544387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
    Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
    Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
    Li XH; Zhao CY; Zhou EL; Lin XJ
    BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
    Ben-Josef E; Guthrie KA; El-Khoueiry AB; Corless CL; Zalupski MM; Lowy AM; Thomas CR; Alberts SR; Dawson LA; Micetich KC; Thomas MB; Siegel AB; Blanke CD
    J Clin Oncol; 2015 Aug; 33(24):2617-22. PubMed ID: 25964250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival.
    Hammad AY; Berger NG; Eastwood D; Tsai S; Turaga KK; Christian KK; Johnston FM; Pawlik TM; Gamblin TC
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):912-920. PubMed ID: 27654107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.
    Jeong H; Kim KP; Jeong JH; Hwang DW; Lee JH; Kim KH; Moon DB; Lee MA; Park SJ; Chon HJ; Park JH; Lee JS; Ryoo BY; Yoo C
    Hepatology; 2023 May; 77(5):1540-1549. PubMed ID: 37070950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
    Hester C; Nassour I; Adams-Huet B; Augustine M; Choti MA; Minter RM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Gastrointest Surg; 2018 Dec; 22(12):2080-2087. PubMed ID: 30030718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
    Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
    Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review.
    Rodriguez RR; Abel S; Mamadgi J; Renz PB; Wegner RE; Raj MS
    J Gastrointest Cancer; 2022 Sep; 53(3):700-708. PubMed ID: 34486086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
    Luvira V; Satitkarnmanee E; Pugkhem A; Kietpeerakool C; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012814. PubMed ID: 34515993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
    Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
    Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.
    Nassour I; Mokdad AA; Porembka MR; Choti MA; Polanco PM; Mansour JC; Minter RM; Wang SC; Yopp AC
    Ann Surg Oncol; 2018 May; 25(5):1193-1201. PubMed ID: 29488187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database.
    Dominguez DA; Wong P; Chen YJ; Singh GP; Fong Y; Li D; Ituarte PHG; Melstrom LG
    Ann Surg Oncol; 2024 Aug; 31(8):4896-4904. PubMed ID: 38443700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients.
    Parsons M; Lloyd S; Johnson S; Scaife C; Soares H; Kim R; Kim R; Garrido-Laguna I; Tao R
    J Gastrointest Cancer; 2023 Jun; 54(2):492-500. PubMed ID: 35445343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
    Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
    Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.